1. Companies
  2. Alcyone Lifesciences
  3. Team

  4. Team

Alcyone Lifesciences

Alcyone Lifesciences

Verified
Pioneers next-generation intra-CSF CNS precision gene-based therapeutics for complex neurological conditions.
Launch date
Employees
11-50 people
Market cap
-
Net debt
-
Enterprise valuation
$92—138m (Dealroom.co estimates Jun 2021.)
Ayer Massachusetts (HQ)
https://alcyonetx.com/
https://twitter.com/alcyonetxhttps://www.facebook.com/pages/Alcyone-Lifesciences/567338463405327https://www.linkedin.com/company/alcyonetherapeutics/
Authorizing premium user...